In a paper published in Brain (available online ahead of print here), we specifically studied a series of demented patients with a clinical diagnosis of Alzheimer’s disease but who had a negative beta-amyloid PET scan. The paper includes cross sectional and longitudinal clinical data, as well as neuroimaging data from structural MRI and FDG-PET.
This publication, led by Gael Chetelat’s group in Caen, France, is the result of a great collaboration with three other world-famous groups:
– The group of Gil Rabinovici at UCSF (+Bill Jagust at UC Berkeley)
– The group led by Chris Rowe and Victor Villemagne in Melbourne
– The group led by Philip Scheltens in Amsterdam